1992
DOI: 10.1002/em.2850190203
|View full text |Cite
|
Sign up to set email alerts
|

Induction of 6‐thioguanine‐resistant mutants in human diploid fibroblasts in vitro with ethylene oxide

Abstract: Human diploid fibroblasts (strain VH-10) were exposed to the direct-acting alkylating agent, ethylene oxide (EtO), in vitro, and the frequency of HPRT mutants was evaluated by selection in medium containing 6-thioguanine. A dose-dependent increase of the mutant frequency was found in the dose range of 2.5-10 mMh of EtO. The EtO-induced mutant frequency increased 5-19 times the background frequency at low or moderately toxic doses, which indicates that EtO is a strong mutagen in human fibroblasts in vitro. The … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1993
1993
2023
2023

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 18 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…The titer and ratio of these factors in the nuclei of brain cells may dictate the profile of genes that are expressed, for example, during reproductive and nonreproductive seasons. Changes in transcription factor concentrations as small as 2-fold to 3-fold have been shown to result in differential regulation of target genes (Struhl et al, 1989;Kolman et al, 1992). In the present study we did not determine relative levels of HasPOU-III and HasPOU-IV transcripts or proteins.…”
Section: Pou Gene Expression and Evolutionmentioning
confidence: 60%
“…The titer and ratio of these factors in the nuclei of brain cells may dictate the profile of genes that are expressed, for example, during reproductive and nonreproductive seasons. Changes in transcription factor concentrations as small as 2-fold to 3-fold have been shown to result in differential regulation of target genes (Struhl et al, 1989;Kolman et al, 1992). In the present study we did not determine relative levels of HasPOU-III and HasPOU-IV transcripts or proteins.…”
Section: Pou Gene Expression and Evolutionmentioning
confidence: 60%
“…Experiments were conducted using human skin fibroblasts (VH10) [46] , immortalised by the human telomerase reverse transcriptase (hTERT) method [47] and supplemented with G418 (25 μg/ml final, AppliChem) for selection. For the investigation of the role of SAGA DUB, HeLa cells (malignant human epithelial adenocarcinoma cells) [48] transfected and stably expressing short hairpin RNA against ATXN7L3 (shATXN7L3) and non-targeting control (shCTL) were used [35] , kindly provided to us by the Tora Lab, IGBMC.…”
Section: Methodsmentioning
confidence: 99%